Cargando…

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

OBJECTIVE: To review existing regulations and policies utilised by countries to enable patient access to orphan drugs. METHODS: A review of the literature (1998 to 2014) was performed to identify relevant, peer-reviewed articles. Using content analysis, we synthesised regulations and policies for ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gammie, Todd, Lu, Christine Y., Babar, Zaheer Ud-Din
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599885/ https://www.ncbi.nlm.nih.gov/pubmed/26451948 http://dx.doi.org/10.1371/journal.pone.0140002

Ejemplares similares

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America
por: Arnold, Renée J.G., et al.
Publicado: (2015)

Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries?
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2010)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2019)

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007)

Policy cooperation and interface issues
por: Vogler, Sabine, et al.
Publicado: (2015)

Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Policies beyond the crisis: lesson learned
por: Vogler, Sabine, et al.
Publicado: (2015)

A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies
por: Merchant, Hamid A., et al.
Publicado: (2022)

Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit!
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2013)

Patient access schemes in Asia-pacific markets: current experience and future potential
por: Lu, Christine Y, et al.
Publicado: (2015)

Recommendations to improve pharmacy practice research in the Middle Eastern Arab countries
por: Obaid, Daneh, et al.
Publicado: (2021)

A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
por: Ocran Mattila, Phyllis, et al.
Publicado: (2023)

Pharmacovigilance in High-Income Countries: Current Developments and a Review of Literature
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2023)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy
por: Babar, Zaheer-Ud-Din
Publicado: (2020)

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012)

Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study
por: Zia, Nadeem, et al.
Publicado: (2021)

Mechanism of coordinated access to orphan drugs
por: DeRidder, R, et al.
Publicado: (2012)

Patient access to orphan drugs in France
por: Bourdoncle, Marion, et al.
Publicado: (2019)

Human resources health supply chains and access to essential medicines
por: Brown, Andrew, et al.
Publicado: (2014)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

New Zealand’s Drug Development Industry
por: Lockhart, Michelle Marie, et al.
Publicado: (2013)

A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022)

The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation
por: Franco, Pedro, et al.
Publicado: (2014)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

Drug shops for stronger health systems: learning from initiatives in six LMICs
por: Lamba, Geetanjali, et al.
Publicado: (2021)

Intradural Disc Herniation: A Case Report and Literature Review
por: Ashraf, Almas, et al.
Publicado: (2020)

Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research
por: Abbas, Nasir, et al.
Publicado: (2021)

Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature
por: Hussain, Rabia, et al.
Publicado: (2023)

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries
por: Czech, Marcin, et al.
Publicado: (2020)

Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology
por: Saeed, Amna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m5s1p9aapo9isk7cvfrvssm8nv